Researchers: Rodrigo Haber Mellen, Otávio Simões Girotto, Eduarda Boni Marques, Lucas Fornari Laurindo, Paulo Cesar Grippa, Claudemir Gregório Mendes, Lorena Natalino Haber Garcia, Marcelo Dib Bechara, Sandra Maria Barbalho, Renata Vargas Sinatora, Jesselina Francisco Dos Santos Haber, Uri Adrian P Flato, Patricia Cincotto Dos Santos Bueno, Claudia Rucco Penteado Detregiachi, Karina Quesada
Sarcopenia is a multifactorial condition related to the loss of muscle mass and strength due to aging, eating habits, physical inactivity, or even caused by another disease. Affected individuals have a higher risk of falls and may be associated with heart disease, respiratory diseases, cognitive impairment, and consequently an increased risk of hospitalization, in addition to causing an economic impact due to the high cost of care during the stay in hospitals. The standardization of appropriate treatment for patients with sarcopenia that could help reduce pathology-related morbidity is necessary. For these reasons, this study aimed to perform a systematic review of the role of nutrition and drugs that could ameliorate the health and quality of life of sarcopenic patients and PRISMA guidelines were followed. Lifestyle interventions have shown a profound impact on sarcopenia treatment but using supplements and different drugs can also impact skeletal muscle maintenance. Creatine, leucine, branched-chain amino acids, omega 3, and vitamin D can show benefits. Although with controversial results, medications such as Metformin, GLP-1, losartan, statin, growth hormone, and dipeptidyl peptidase 4 inhibitors have also been considered and can alter the sarcopenic’s metabolic parameters, protect against cardiovascular diseases and outcomes, while protecting muscles.
References
- Sarcopenia during COVID-19 lockdown restrictions: long-term health effects of short-term muscle loss.
- Exercise and mitochondrial mechanisms in patients with sarcopenia.
- Omega-3 Supplementation Improves Isometric Strength But Not Muscle Anabolic and Catabolic Signaling in Response to Resistance Exercise in Healthy Older Adults.
- Klotho: An Emerging Factor With Ergogenic Potential.
- Physical Exercise and Myokines: Relationships with Sarcopenia and Cardiovascular Complications.
- Extra Virgin Olive Oil (EVOO), a Mediterranean Diet Component, in the Management of Muscle Mass and Function Preservation.
- Sarcopenia and type 2 diabetes mellitus: a bidirectional relationship.
- Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments.
- Whey Protein, Leucine- and Vitamin-D-Enriched Oral Nutritional Supplementation for the Treatment of Sarcopenia.
- Nutritional Supplements to Support Resistance Exercise in Countering the Sarcopenia of Aging.
- Muscular Atrophy and Sarcopenia in the Elderly: Is There a Role for Creatine Supplementation?
- Effectiveness of Creatine Supplementation on Aging Muscle and Bone: Focus on Falls Prevention and Inflammation.
- Variables Influencing the Effectiveness of Creatine Supplementation as a Therapeutic Intervention for Sarcopenia.
- Expert Opinion on Benefits of Long-Chain Omega-3 Fatty Acids (DHA and EPA) in Aging and Clinical Nutrition.
- Nutrition and Sarcopenia-What Do We Know?
- The role of omega-3 in the prevention and treatment of sarcopenia.
- Long-Term Moderate Exercise Combined with Metformin Treatment Induces an Hormetic Response That Prevents Strength and Muscle Mass Loss in Old Female Wistar Rats.